You do not have permission to edit this page, for the following reasons:

This IP address has been blocked from editing Wikipedia.
This does not affect your ability to read Wikipedia pages.
Most people who see this message have done nothing wrong. Some kinds of blocks restrict editing from specific service providers or telecom companies in response to recent abuse or vandalism, and can sometimes affect other users who are unrelated to that abuse. Review the information below for assistance if you do not believe that you have done anything wrong.

The IP address or range 18.207.0.0/16 has been blocked (disabled) by ‪ST47‬ for the following reason(s):

The IP address that you are currently using has been blocked because it is believed to be a web host provider. To prevent abuse, web hosts may be blocked from editing Wikipedia.
You will not be able to edit Wikipedia using a web host provider because it hides your IP address, much like a proxy or VPN.
We recommend that you attempt to use another connection to edit. For example, if you use a proxy or VPN to connect to the internet, turn it off when editing Wikipedia. If you edit using a mobile connection, try using a Wi-Fi connection, and vice versa. If you are using a corporate internet connection, switch to a different Wi-Fi network. If you have a Wikipedia account, please log in.
If you do not have any other way to edit Wikipedia, you will need to request an IP block exemption.

How to appeal if you are confident that your connection does not use a web host's IP address:
If you are confident that you are not using a web host, you may appeal this block by adding the following text on your talk page: ((unblock|reason=Caught by a web host block but this host or IP is not a web host. My IP address is _______. Place any further information here. ~~~~)). You must fill in the blank with your IP address for this block to be investigated. Your IP address can be determined here. Alternatively, if you wish to keep your IP address private you can use the unblock ticket request system. There are several reasons you might be editing using the IP address of a web host (such as if you are using VPN software or a business network); please use this method of appeal only if you think your IP address is in fact not a web host.

Administrators: The IP block exemption user right should only be applied to allow users to edit using web host in exceptional circumstances, and they should usually be directed to the functionaries team via email. If you intend to give the IPBE user right, a CheckUser needs to take a look at the account. This can be requested most easily at SPI Quick Checkuser Requests. Unblocking an IP or IP range with this template is highly discouraged without at least contacting the blocking administrator.

This block will expire on 01:06, 24 April 2026.

Even when blocked, you will usually still be able to edit your user talk page, as well as email administrators and other editors.

For information on how to proceed, please read the FAQ for blocked users and the guideline on block appeals. The guide to appealing blocks may also be helpful.

Other useful links: Blocking policy · Help:I have been blocked
Your IP address is in a range that has been blocked on all Wikimedia Foundation wikis. The block was made by ‪Jon Kolbert‬. The reason given is Open proxy/Webhost: See the help page if you are affected .
- Start of block: 05:37, 21 February 2024
- Expiry of block: 05:37, 21 February 2029
Your current IP address is 18.207.245.152. The blocked range is 18.207.0.0/16. Please include all above details in any queries you make. If you believe you were blocked by mistake, you can find additional information and instructions in the No open proxies global policy. Otherwise, to discuss the block please post a request for review on Meta-Wiki. You could also send an email to the stewards VRT queue at stewards@wikimedia.org including all above details.

You can view and copy the source of this page:

((Short description|American trade association for medical devices))
((multiple issues|
((Refimprove|date=March 2017))
((Advert|date=March 2017))
((Undisclosed paid|date=September 2020))
))
((Infobox company
| name = AdvaMed
| industry = [[Medical Technology]]
| hq_location = [[Washington, D.C.]]
| key_people = Scott Whitaker (CEO) <br> Nadim Yared (Board Chairman)
))

'''AdvaMed''', or the '''Advanced Medical Technology Association''', is an American [[medical device]] [[trade association]], based in [[Washington, D.C.]] It is the largest medical device association in the world<ref>((cite web|url=https://fmdic.org/about/members/|title=Member Organizations ((!)) FDA Medical Device Industry Coalition|publisher=FMDIC|accessdate=June 25, 2018))</ref> with U.S. and international members who are [[medical technology]] companies (medical devices, diagnostic products, and health information systems) that collectively represents 80% of U.S. medical technology firms in the United States, that produce close to 90% of annual health care technology purchases in the United States and more than 40% globally.((cn|date=March 2017))

Scott Whitaker is AdvaMed’s President and [[Chief executive officer|CEO]],<ref>((cite news|title=AdvaMed Names Scott Whitaker CEO and President|url=https://www.prnewswire.com/news-releases/advamed-names-scott-whitaker-ceo-and-president-300222754.html|work=PRnewswire|date=February 18, 2016|accessdate=June 25, 2018))</ref> and its current Board Chairman is Nadim Yared, also serves as President and CEO of CVRx, Inc.<ref>((cite news|title=Report: CVRx CEO Yared tapped for AdvaMed chairman|url=https://www.massdevice.com/report-cvrx-ceo-yared-tapped-advamed-chairman-personnel-moves-june-27-2016/|work=Mass Device|date=June 27, 2016|accessdate=June 25, 2018))</ref>

==Policies==
AdvaMed’s website states that the organization promotes competitive policies that foster the highest ethical standards, rapid product approvals, appropriate reimbursement, and access to international markets.<ref>((cite web|url=https://www.advamed.org/about-advamed|title=About AdvaMed|publisher=AdvaMed|accessdate=June 25, 2018))</ref>

The Innovation Agenda identifies five core policy pillars: improving the [[Food and Drug Administration|FDA]]’s regulatory processes, restructuring CMS’s coverage and payment processes, reforming the [[Taxation in the United States|U.S. tax system]] to create a level playing field, improving access to international markets, and supporting the maintenance and growth of an R&D infrastructure.<ref>((cite web|url=https://www.advamed.org/issues/innovation-agenda-0|title=Innovation Agenda|publisher=AdvaMed|accessdate=June 25, 2018))</ref>

===Medical Device Tax===
AdvaMed has consistently and strongly opposed the 2.3% medical device excise tax imposed by the [[Affordable Care Act|Affordable Care Act in 2013]], stating that it harms job creation, deters medical innovation needed to save and improve patients’ lives, and inhibits economic growth.((cn|date=March 2017))

In 2015, Congress temporarily suspended the medical device excise tax. While AdvaMed supported the suspension, the association continues to push for full and permanent repeal of the tax. Whitaker has stated that ''“It’s not enough to delay or further suspend this disruptive tax, even if for a longer period of time. It simply does not give industry the certainty and confidence it needs to make these critical long-term R&D investments. The time is now. We stand ready to help this administration, Congress, and the nation get Americans back on the job."''<ref>((cite news|url=https://www.mpo-mag.com/contents/view_breaking-news/2017-01-10/surveys-illustrate-positive-results-of-device-tax-suspension/|title=Surveys Illustrate Positive Results of Device Tax Suspension|work=Your online source for medical device product information - Medical Product Outsourcing|date=January 10, 2017|accessdate=June 25, 2018))</ref>

In February 2017, AdvaMed released data from the [[U.S. Department of Commerce]] revealing that the U.S. medical technology industry saw its jobs ranks fall by nearly 29,000 while the medical device excise tax was in effect.<ref>((cite news|url=https://medcitynews.com/2017/02/medtech-lobby-says-29000-jobs-lost-device-tax-effect/|title=Medtech lobby says 29,000 jobs were lost while device tax was in effect|work=MedCity News|author=Arundhati Parmar|date=February 8, 2017|accessdate=June 25, 2018))</ref>

===AdvaMed and FDA's Finalized Human Factors Guidance for Combination Products===
In 2016, the FDA released the first draft of its guidance on applying [[Human factors and ergonomics|human factors engineering]] principles to combination products. It immediately faced criticism from AdvaMed, citing overly burdensome requirements. Seven years later, in 2023, the FDA finalized its guidance and released the final draft. It is intended to complement the FDA's 2011 device guidance and a separate document on "Safety Considerations for Product Design to Minimize Medication Errors." The finalized guidance addresses specific questions that may arise during the development of combination products, focusing on user interactions and clinical trials support.<ref>((Cite web |url=https://www.medtechdive.com/news/FDA-finalizes-combination-product-guidance/693498/ |title=FDA finalizes combination product guidance 7 years after sharing draft |last=Paul Taylor |first=Nick))</ref>

== VentConnect platform ==
In August 2020, The Advanced Medical Technology Association (AdvaMed) reported that VentConnect is growing its network. The updated MedDeviceNetwork network (MedDeviceNetwork.org) would expand past ventilators and incorporate many emerging medical devices in the current battle against [[COVID-19 pandemic|COVID-19]] and other potential health crises that America's doctors and caregivers require.<ref>((Cite web|last=|first=|date=3 August 2020|title=AdvaMed expands VentConnect platform to advance production of COVID medtech|url=https://www.dotmed.com/news/story/52063|url-status=live|archive-url=https://web.archive.org/web/20200918235610/https://www.dotmed.com/news/story/52063 |archive-date=2020-09-18 |access-date=26 August 2020|website=dotmed))</ref>

==References==
((Reflist))

==External links==
*[https://www.advamed.org AdvaMed's Official Web site]

[[Category:Health industry trade groups based in the United States]]
[[Category:Medical and health organizations based in Washington, D.C.]]

Pages transcluded onto the current version of this page (help):

AdvaMed (edit)
Template:Advert (view source) (template editor protected)
Template:Ambox (view source) (template editor protected)
Template:Category handler (view source) (protected)
Template:Citation needed (view source) (protected)
Template:Cite news (view source) (protected)
Template:Cite web (view source) (protected)
Template:Cn (view source) (template editor protected)
Template:Comma separated entries (view source) (template editor protected)
Template:Delink (view source) (protected)
Template:Find sources mainspace (view source) (template editor protected)
Template:Fix (view source) (protected)
Template:Fix/category (view source) (protected)
Template:Infobox (view source) (template editor protected)
Template:Infobox company (view source) (template editor protected)
Template:Longitem (view source) (template editor protected)
Template:Main other (view source) (protected)
Template:More citations needed (view source) (template editor protected)
Template:Multiple issues (view source) (template editor protected)
Template:Multiple issues/styles.css (view source) (template editor protected)
Template:Pagetype (view source) (protected)
Template:Refimprove (view source) (template editor protected)
Template:Reflist (view source) (protected)
Template:Reflist/styles.css (view source) (protected)
Template:SDcat (view source) (protected)
Template:Short description (view source) (protected)
Template:Short description/lowercasecheck (view source) (protected)
Template:Template other (view source) (protected)
Template:Undisclosed paid (view source) (template editor protected)
Template:Wikidata (view source) (template editor protected)
Module:Arguments (view source) (protected)
Module:Category handler (view source) (protected)
Module:Category handler/blacklist (view source) (protected)
Module:Category handler/config (view source) (protected)
Module:Category handler/data (view source) (protected)
Module:Category handler/shared (view source) (protected)
Module:Check for clobbered parameters (view source) (template editor protected)
Module:Check for unknown parameters (view source) (protected)
Module:Citation/CS1 (view source) (protected)
Module:Citation/CS1/COinS (view source) (protected)
Module:Citation/CS1/Configuration (view source) (protected)
Module:Citation/CS1/Date validation (view source) (protected)
Module:Citation/CS1/Identifiers (view source) (protected)
Module:Citation/CS1/Utilities (view source) (protected)
Module:Citation/CS1/Whitelist (view source) (protected)
Module:Citation/CS1/styles.css (view source) (protected)
Module:Delink (view source) (protected)
Module:Disambiguation/templates (view source) (protected)
Module:Find sources (view source) (template editor protected)
Module:Find sources/config (view source) (template editor protected)
Module:Find sources/links (view source) (template editor protected)
Module:Find sources/templates/Find sources mainspace (view source) (template editor protected)
Module:Infobox (view source) (template editor protected)
Module:Infobox/styles.css (view source) (template editor protected)
Module:InfoboxImage (view source) (template editor protected)
Module:Message box (view source) (protected)
Module:Message box/ambox.css (view source) (protected)
Module:Message box/configuration (view source) (protected)
Module:Namespace detect/config (view source) (protected)
Module:Namespace detect/data (view source) (protected)
Module:Pagetype (view source) (protected)
Module:Pagetype/config (view source) (protected)
Module:Pagetype/disambiguation (view source) (protected)
Module:Pagetype/setindex (view source) (protected)
Module:Pagetype/softredirect (view source) (protected)
Module:SDcat (view source) (protected)
Module:Separated entries (view source) (protected)
Module:String (view source) (protected)
Module:TableTools (view source) (protected)
Module:Unsubst (view source) (protected)
Module:Wd (view source) (template editor protected)
Module:Wd/i18n (view source) (template editor protected)
Module:WikidataIB (view source) (template editor protected)
Module:WikidataIB/nolinks (view source) (template editor protected)
Module:WikidataIB/titleformats (view source) (template editor protected)
Module:Wikitext Parsing (view source) (protected)
Module:Yesno (view source) (protected)

Return to AdvaMed.

Retrieved from "https://en.wikipedia.org/wiki/AdvaMed"